Federation Des Caisses Desjardins Du Quebec Cardiol Therapeutics Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$18.9 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2024	SELL	$0.47 - $0.81 $1,410 - $2,430	-3,000 Reduced 62.5%	1,800 $878,000
Q3 2022 Aug 14, 2024	SELL	$1.02 - $1.41 $3,060 - $4,230	-3,000 Reduced 38.46%	4,800 $4.87 Million
Q1 2022 Aug 14, 2024	BUY	$1.25 - $2.31 $9,750 - $18,018	7,800 New	7,800 $12 Million
Q3 2021 Aug 30, 2024	BUY	$2.03 - $4.8 $12,179 - $28,800	6,000 New	6,000 $24.5 Million

Others Institutions Holding CRDL

# of Institutions

Shares Held

5.07M

Call Options Held

5.2K

Put Options Held

9.5K

Tejara Capital LTD London, X0

1.77M
Shares

$2.28 Million
1.67% of portfolio
Advisor Shares Investments LLC Bethesda, MD

1.17M
Shares

$1.51 Million
0.46% of portfolio
Mmcap International Inc. Spc Grand Cayman, E9

796K
Shares

$1.03 Million
0.36% of portfolio
Lion Street Advisors, LLC

273K
Shares

$352,532
0.19% of portfolio
Foundations Investment Advisors, LLC

162K
Shares

$208,915
0.01% of portfolio

View Full List

About Cardiol Therapeutics Inc.

Ticker CRDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 61,942,500
Market Cap $79.9M
Description
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...

More about CRDL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account